Table 2

Comparison of the characteristics of the patients with Kawasaki disease according to the level of MMP-9

VariableMMP-9 >1078.68
(n=37)
MMP-9 ≤1078.68
(n=93)
P value
Male, n (%)24 (64.90)66 (71.00)0.496
Age (mo)34 (15–50)27 (12–42)0.020
Fever duration (d)7 (6–12)7 (5–12.5)0.159
IKD, n (%)18 (48.60)53 (57.00)0.389
White cell (×109/L)15.16 (10.58–19.95)12.49 (8.50–17.82)0.031
NE%0.80 (0.53–1.50)0.58 (0.40–0.82)0.019
LY%0.28 (0.15–0.52)0.42 (0.29–0.66)0.143
PLT (×109/L)348.00 (280.00–441.50)312.00 (223.50–416.00)0.272
ALB (g/L)31.40 (29.30–34.75)33.50 (30.00–36.20)0.131
CRP (mg/L)88.00 (18.50–131.00)21.00 (7.87–53.53)0.001
ESR (mm/h)89.57±26.4073.44±31.540.007
Red cell (×1012/L)4.28±0.594.24±0.520.656
HGB (g/L)113.70±15.39111.14±13.750.356
MO%0.05 (0.03–0.08)0.07 (0.05–0.10)0.012
EO%0.01 (0.00–0.03)0.02 (0.01–0.05)0.157
IL-6 (pg/mL)71.37 (22.66–141.89)37.71 (14.41–95.64)0.075
CAL, n (%)33 (46.24)43 (89.20)0.001
  • Data are mean±SD, P50 (P25–P75) and n (%).

  • ALB, albumin; CAL, coronary artery lesion; CRP, C-reactive protein; EO%, eosinophil percentage; ESR, erythrocyte sedimentation rate; HGB, hemoglobin; IKD, incomplete Kawasaki disease; IL-6, interleukin-6; LY%, lymphocyte percentage; MMP-9, matrix metalloproteinase-9; MO%, monocyte percentage; NE%, neutrophil percentage; PLT, platelet.